Achieving Undetectable HDV RNA at End of Therapy With Bulevirtide With or Without PegIFNα is Strongly Associated With Posttreatment Virologic Response in CHD

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
May 7-10, 2025
Amsterdam the Netherlands


Achieving Undetectable HDV RNA at End of Therapy With Bulevirtide With or Without PegIFNα is Strongly Associated With Posttreatment Virologic Response in CHD

	EASL 2025 May 7-10 Amsterdam